ORGANOGENESIS HOLDINGS INC. - CLASS A

Organogenesis Holdings Inc. to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

07 сен 2022 06:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Receives FDA Clearance for Next Generation PuraPly Surgical Solution

15 авг 2022 06:00:01 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Second Quarter 2022 Financial Results

09 авг 2022 15:05:02 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2022 Financial Results on August 9, 2022

30 июн 2022 06:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports First Quarter 2022 Financial Results

10 май 2022 15:05:02 Источник Nasdaq GlobeNewswire

Organogenesis Appoints Michele Korfin and Gilberto Quintero, Ph.D. to Board of Directors

05 май 2022 15:05:02 Источник Nasdaq GlobeNewswire

Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring 2022 Conference

05 апр 2022 15:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022

05 апр 2022 15:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Named One of 50 Highest Growth Companies in Massachusetts by the Boston Business Journal

17 мар 2022 08:00:01 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Present at the Oppenheimer Healthcare Conference

08 мар 2022 06:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Guidance

01 мар 2022 15:05:01 Источник Nasdaq GlobeNewswire

Organogenesis Appoints Michael J. Driscoll, Ed.D. to Board of Directors

17 фев 2022 15:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February

11 фев 2022 06:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022

07 фев 2022 06:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Appoints Prathyusha Duraibabu to Board of Directors

22 ноя 2021 06:00:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Third Quarter and First Nine Months 2021 Financial Results

09 ноя 2021 15:05:01 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Participate in the Credit Suisse 30th Annual Healthcare Conference

08 ноя 2021 06:30:00 Источник Nasdaq GlobeNewswire

Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference

27 окт 2021 08:25:10 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021

07 окт 2021 15:05:00 Источник Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

10 сен 2021 08:00:00 Источник Nasdaq GlobeNewswire